<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The" exact="influenza" post="virus-host interaction is a classic arms race. The recurrent"/>
 <result pre="classic arms race. The recurrent and evolving nature of the" exact="influenza" post="virus family allows a single host to be infected"/>
 <result pre="host to be infected several times. Locked in co-evolution, recurrent" exact="influenza" post="virus infection elicits continual refinement of the host immune"/>
 <result pre="host immune system. Here we give historical context of circulating" exact="influenza" post="viruses to understand how the individual immune history is"/>
 <result pre="the individual immune history is mirrored by the history of" exact="influenza" post="virus circulation. Original Antigenic Sin was first proposed as"/>
 <result pre="first proposed as the negative influence of the host’s first" exact="influenza" post="virus infection on the next and Imprinting modernizes Antigenic"/>
 <result pre="the continual refinement of the host immune system with each" exact="influenza" post="virus infection. We discuss imprinting and the interplay of"/>
 <result pre="influenza virus infection. We discuss imprinting and the interplay of" exact="influenza" post="virus homology, vaccination, and host age establishing preimmunity. We"/>
 <result pre="for future investigation. Understanding the effects of antigenic variable recurrent" exact="influenza" post="virus infection on immune refinement will advance vaccination strategies,"/>
 <result pre="as pandemic preparedness. immune response original antigenic sin imprinting preimmunity" exact="influenza" post="virus antigenic drift antigenic shift orthomyxoviridae Spanish influenza pandemic"/>
 <result pre="imprinting preimmunity influenza virus antigenic drift antigenic shift orthomyxoviridae Spanish" exact="influenza" post="pandemic 1. Introduction: Influenza Viruses are the Archetype Emerging"/>
 <result pre="the ability to infect the vulnerable human population [4]. Yearly," exact="influenza" post="viruses infect between 5% and 15% of the population"/>
 <result pre="that every person will be infected or exposed to the" exact="influenza" post="virus by the time they are four years old."/>
 <result pre="time they are four years old. Furthermore, considering prominent government-supported" exact="influenza" post="vaccination programs, the age of first influenza virus exposure"/>
 <result pre="considering prominent government-supported influenza vaccination programs, the age of first" exact="influenza" post="virus exposure is most likely lower. Since influenza viruses"/>
 <result pre="of first influenza virus exposure is most likely lower. Since" exact="influenza" post="viruses cycle yearly in the human population and the"/>
 <result pre="previous infection is not life-long [6], people are exposed to" exact="influenza" post="viruses recurrently. This means that everyone, with the exception"/>
 <result pre="that everyone, with the exception of newborn infants, has an" exact="influenza" post="immune history. Humans build a complex immune history due"/>
 <result pre="a complex immune history due to repeated exposures with new" exact="influenza" post="strains from infection and seasonal vaccinations. The influence of"/>
 <result pre="1960s. Dr. Thomas Francis Jr. suggested that a person’s first" exact="influenza" post="virus infection would be deleterious to the clinical outcome"/>
 <result pre="Immune history is not simply composed of the host’s first" exact="influenza" post="virus infection. Rather, the interaction between the immune system"/>
 <result pre="virus infection. Rather, the interaction between the immune system and" exact="influenza" post="viruses is dynamic with each exposure. Each host-pathogen interaction"/>
 <result pre="stalk [15]. The constant circulation of a heterogeneous pool of" exact="influenza" post="viruses allows for many possible permutations for viral infection"/>
 <result pre="Heterotypic sequential infections (Table 1). The influence of a previous" exact="influenza" post="virus exposure on the outcome of a subsequent infection"/>
 <result pre="infection may be both beneficial and deleterious. A person’s first" exact="influenza" post="infection is a significant event, the imprinting event, which"/>
 <result pre="memory cells [16]. Subsequent infections lead to cumulative effects of" exact="influenza" post="viruses on the immune background which shape future responses"/>
 <result pre="responses [17]. We propose that a person’s immune history of" exact="influenza" post="virus infections should be known as preimmunity. The schematic"/>
 <result pre="an individual’s immune landscape may evolve during seasonal exposures to" exact="influenza" post="viruses and vaccinations (Figure 1). The imprinting event that"/>
 <result pre="target surface and internal viral epitopes specific to this first" exact="influenza" post="virus which remain prominent throughout life [18]. Most antibodies"/>
 <result pre="to antibody specificity and B cell longevity. Following a new" exact="influenza" post="virus infection, the resulting immune constellation is dependent on"/>
 <result pre="the pre-existing immune specificity and the characteristics of the next" exact="influenza" post="virus infection (virus strain, subtype, lineage, or type). Below"/>
 <result pre="subtype, lineage, or type). Below we review the literature surrounding" exact="influenza" post="virus immune imprinting and preimmunity. We first outline the"/>
 <result pre="preimmunity. We first outline the development of preimmunity by discussing" exact="influenza" post="virology, influenza history, and primary immune responses. This sets"/>
 <result pre="first outline the development of preimmunity by discussing influenza virology," exact="influenza" post="history, and primary immune responses. This sets the stage"/>
 <result pre="of host preimmunity will contribute to the next generation of" exact="influenza" post="vaccines. 2. Influenza Virus Biology Enables Frequent Antigenic Change"/>
 <result pre="Enables Frequent Antigenic Change The segmented RNA genome of the" exact="influenza" post="virus family (Orthomyxoviridae) facilitates antigenic variability [20]. The family"/>
 <result pre="types: A, B, C (Figure 2), and D [21,22]. Briefly," exact="influenza" post="C and D viruses are not regarded as health"/>
 <result pre="D viruses are not regarded as health threats. In humans," exact="influenza" post="C virus causes mild illness while type D virus"/>
 <result pre="virus is incapable of human infection [23]. The surface of" exact="influenza" post="C virus is defined by a single spike protein"/>
 <result pre="capabilities, and enzymatic activity for egress [23]. Although antibodies to" exact="influenza" post="C virus are detected early in life [23], little"/>
 <result pre="NA [25] surface proteins are the immunodominant proteins of the" exact="influenza" post="virus which is why they have been the focus"/>
 <result pre="the rearrangement of genomic RNA segments between two or more" exact="influenza" post="viruses [41]. Antigenic Drift leads to seasonal influenza epidemics"/>
 <result pre="or more influenza viruses [41]. Antigenic Drift leads to seasonal" exact="influenza" post="epidemics while shift is the cause of pandemic influenza"/>
 <result pre="seasonal influenza epidemics while shift is the cause of pandemic" exact="influenza" post="virus outbreaks [41]. Both avenues lead to antigenically divergent"/>
 <result pre="Using experimental studies, the early stages of a host’s first" exact="influenza" post="virus infection have been defined by the antiviral response"/>
 <result pre="By summarizing the knowledge of the immune responses to primary" exact="influenza" post="virus infection we create a reference point for the"/>
 <result pre="dissemination, and recruiting effector cells for viral clearance [42]. Since" exact="influenza" post="viruses are transmitted through the respiratory route, the initial"/>
 <result pre="through the respiratory route, the initial site of infection for" exact="influenza" post="viruses is the respiratory epithelium [40,43,44,45]. Specifically, ciliated pseudostratified"/>
 <result pre="immune cells for viral clearance [40]. NK cells aid in" exact="influenza" post="viral clearance by recognizing and lysing influenza virus-infected cells"/>
 <result pre="cells aid in influenza viral clearance by recognizing and lysing" exact="influenza" post="virus-infected cells [46]. Alveolar macrophages phagocytose virus infected cells"/>
 <result pre="bridging innate immunity to the targeted adaptive immune responses during" exact="influenza" post="virus infection [50]. Conventional DCs sit under the epithelium"/>
 <result pre="survey the airway environment with their dendrites [34]. Detection of" exact="influenza" post="virus initiates DC up-regulation of the chemokine receptor CCR7"/>
 <result pre="to kill virus infected cells. Global gene expression analysis of" exact="influenza" post="infection in ferrets has shown that the host immune"/>
 <result pre="this review will concentrate on the humoral immune response during" exact="influenza" post="virus infection in the preimmune host. With this in"/>
 <result pre="migrate to the lymph node transporting with them the acquired" exact="influenza" post="virus antigen. In the lymph node, naïve CD8+ T"/>
 <result pre="T cells have greater potential for cross-reactivity between antigenically divergent" exact="influenza" post="virus strains since these cells can target internal conserved"/>
 <result pre="T cell specific clones can increase the recovery time of" exact="influenza" post="virus secondary infections. The primary humoral response to infection"/>
 <result pre="plasma cells producing antibodies targeted at viral epitopes. During primary" exact="influenza" post="virus infection, a large and diverse pool of antibodies"/>
 <result pre="of antibodies are produced and circulated [17]. Animal modeling of" exact="influenza" post="virus infection in naïve hosts has shown that most"/>
 <result pre="memory B cells are lifelong since antibodies specific to historical" exact="influenza" post="viruses have been detected in humans decades after initial"/>
 <result pre="Immunological Memory Infection-reinfection or sequential infection experiments attempt to recapitulate" exact="influenza" post="seasonality using animal models. The host is primed with"/>
 <result pre="using animal models. The host is primed with an initial" exact="influenza" post="virus before a challenge with a secondary infection following"/>
 <result pre="[13]. Above we defined the exposure permutations in terms of" exact="influenza" post="virus antigenicity as monosubtypic homologous, monosubtypic heterologous, heterosubtypic, and"/>
 <result pre="contraction phase of the primary adaptive immune response. For the" exact="influenza" post="virus-host interaction, the interval of time between a primary"/>
 <result pre="Virus Circulation Mirrors the Human Influenza Background The history of" exact="influenza" post="virus circulation is encompassed within the individual. In each"/>
 <result pre="will briefly review the modern history (past ~150 years) of" exact="influenza" post="virus circulation to understand the epidemiological and immunological outcomes"/>
 <result pre="virus circulation to understand the epidemiological and immunological outcomes of" exact="influenza" post="virus infection and vaccination. The influenza A virus was"/>
 <result pre="and immunological outcomes of influenza virus infection and vaccination. The" exact="influenza" post="A virus was first identified as the etiological agent"/>
 <result pre="virus was first identified as the etiological agent of human" exact="influenza" post="in 1933 shortly after the advent of electron microscopy"/>
 <result pre="the agent responsible for influenza-like epidemics/pandemics such as the 1918" exact="influenza" post="pandemic were not readily determined [74]. The constructed timeline"/>
 <result pre="timeline (Figure 3) starting in 1889 shows the history of" exact="influenza" post="A and B virus circulation in the human population."/>
 <result pre="human population. There have been six presumptive pandemics caused by" exact="influenza" post="A viruses since 1889 that have defined the immunological"/>
 <result pre="the 1918 pandemic occurred prior to the discovery of the" exact="influenza" post="virus [1,6]. The etiology of these disease outbreaks was"/>
 <result pre="The H2N2 virus was usurped by the introduction of the" exact="influenza" post="A virus subtype H3N2 of swine origin which emerged"/>
 <result pre="be the population’s previous immunity to sub-immunodominant domains on the" exact="influenza" post="virus, i.e., the HA stalk and the neuraminidase [28]."/>
 <result pre="stalk and the neuraminidase [28]. H3N2 circulated as the only" exact="influenza" post="A virus for nine years, until H1N1 resurfaced in"/>
 <result pre="emergence of an antigenically novel H1N1 &quot;lineage�? caused the sixth" exact="influenza" post="virus pandemic [80]. The virus, which was a reassortment"/>
 <result pre="The virus, which was a reassortment of human, swine, and" exact="avian influenza" post="viruses, replaced the former seasonal H1N1 virus &quot;lineage�? which"/>
 <result pre="virus, which was a reassortment of human, swine, and avian" exact="influenza" post="viruses, replaced the former seasonal H1N1 virus &quot;lineage�? which"/>
 <result pre="and imprinting [81]. Human infections of zoonotic strains of other" exact="influenza" post="A virus subtypes such as H5N1, H6N2, H7N1, H7N7,"/>
 <result pre="hundreds of human infections [81,83]. During 1891 to present day," exact="influenza" post="B viruses have been co-circulating, creating a complex immune"/>
 <result pre="Influenza B was identified in 1942 and added to the" exact="influenza" post="vaccine to create a bivalent vaccine [73] (Figure 3)."/>
 <result pre="a bivalent vaccine [73] (Figure 3). The WHO initiated circulating" exact="influenza" post="virus surveillance in 1973, which led to the discovery"/>
 <result pre="in the late 1980s [73]. By viewing the history of" exact="influenza" post="virus circulation through the lens of imprinting, researchers can"/>
 <result pre="make assumptions about individual host imprinting and immune history. The" exact="influenza" post="virus strain that an individual imprinted upon can be"/>
 <result pre="of H1N1 viruses since it was the only subtype of" exact="influenza" post="A circulating in those years [16]. Those born between"/>
 <result pre="Since there was a sequential emergence and replacement of the" exact="influenza" post="A virus subtypes (H1N1, H2N2, and H3N2) the current"/>
 <result pre="much variability for imprinted immunity. Moreover, the sequential nature of" exact="influenza" post="virus circulation has led to heterosubtypic infection-reinfections throughout history."/>
 <result pre="(sH1N1) imprinting with a 2009 H1N1 reinfection (sH1N1-&amp;gt;2009 H1N1). Since," exact="influenza" post="B viruses have co-circulated during A virus flux, there"/>
 <result pre="during A virus flux, there is further complexity to human" exact="influenza" post="virus preimmunity. Studies are only beginning to uncover the"/>
 <result pre="of Preimmunity We know that extrapolating results from naïve animal" exact="influenza" post="virus studies to human disease is limited due the"/>
 <result pre="to human disease is limited due the existence of human" exact="influenza" post="preimmunity [87]. Below we review the recent literature of"/>
 <result pre="preimmunity [87]. Below we review the recent literature of sequential" exact="influenza" post="virus infection using laboratory-controlled experiments with animal models of"/>
 <result pre="influenza virus infection using laboratory-controlled experiments with animal models of" exact="influenza" post="preimmunity. The conclusions are then synthesized with findings from"/>
 <result pre="preimmune host is re-exposed to the same or slightly drifted" exact="influenza" post="virus strain. To investigate the nuanced humoral antibody changes"/>
 <result pre="of age) and adults (28–74 years of age) following seasonal" exact="influenza" post="virus vaccination. The samples were subjected to HAI and"/>
 <result pre="hypothesize that the generation of this antibody occurred following sequential" exact="influenza" post="infections which occurred during the donor’s lifetime which encompassed"/>
 <result pre="exposures to sequential MsHe viruses in the course of historical" exact="influenza" post="pandemics: H2N2 -&amp;gt; H3N2 -&amp;gt; H1N1. Relatedly, other researchers"/>
 <result pre="stalk reactive antibodies, a wider breadth of protection against evolving" exact="influenza" post="viruses may be achieved [31,99]. Specifically, one strategy has"/>
 <result pre="chimeric HA molecule containing the stalk region from the original" exact="influenza" post="HA protein but an HA head containing little a.a."/>
 <result pre="far more complex than that of experimental animal models, personal" exact="influenza" post="virus exposure history can be deduced. As discussed previously,"/>
 <result pre="previously, cross-referencing a person’s birth year against the history of" exact="influenza" post="A and B virus circulation we can surmise a"/>
 <result pre="The data suggested that antibodies previously generated from past seasonal" exact="influenza" post="virus infections (MsHe infection) had a negative impact on"/>
 <result pre="virus in sequence. Each year, H1N1, H3N2, B-Yamagata, and B-Victoria" exact="influenza" post="virus strains circulate in the human population. Despite the"/>
 <result pre="population. Despite the continuing circulation of both A and B" exact="influenza" post="viruses, there is a paucity of information regarding heterotypic"/>
 <result pre="interseasonal as well as intraseasonal. In the northern hemisphere, the" exact="influenza" post="season begins in October lasting until April and peaks"/>
 <result pre="until April and peaks early January. Typically, in each season" exact="influenza" post="A cases are prominent in the first half to"/>
 <result pre="first half to three quarters of the season [101,102]. As" exact="influenza" post="A human cases begin to decline, there is an"/>
 <result pre="to decline, there is an increase in the prominence of" exact="influenza" post="B viruses [101,102] suggesting viral interference or the opportunistic"/>
 <result pre="viruses [101,102] suggesting viral interference or the opportunistic infection of" exact="influenza" post="B viruses in immunosuppressed hosts. One human study documented"/>
 <result pre="medical intervention were documented to have been infected with an" exact="influenza" post="A strain and then reinfected with an influenza B"/>
 <result pre="with an influenza A strain and then reinfected with an" exact="influenza" post="B virus during the same season [103]. All children"/>
 <result pre="without cross-protection. Moreover, other studies have showed prominent co-infections of" exact="influenza" post="A and influenza B viruses [104]. Further study is"/>
 <result pre="other studies have showed prominent co-infections of influenza A and" exact="influenza" post="B viruses [104]. Further study is needed to understand"/>
 <result pre="is needed to understand the mechanisms of immune activation or" exact="suppression" post="during sequential heterotypic and co-infections of two influenza virus"/>
 <result pre="activation or suppression during sequential heterotypic and co-infections of two" exact="influenza" post="virus types. 7. Vaccination Preimmunity May Influence Future Vaccination"/>
 <result pre="Vaccination Preimmunity May Influence Future Vaccination Outcome Despite immune history," exact="influenza" post="viruses are a recurrent and as yet unsolved public"/>
 <result pre="estimated at 500,000 people worldwide by the WHO [79,102,105]. Yearly" exact="influenza" post="vaccination is recommended by the National Advisory Committee on"/>
 <result pre="Health Organization (WHO) as the most effective strategy for reducing" exact="influenza" post="burden [22,106,107]. The low effectiveness of the seasonal influenza"/>
 <result pre="reducing influenza burden [22,106,107]. The low effectiveness of the seasonal" exact="influenza" post="vaccine has been attributed to the frequent mutations in"/>
 <result pre="has previously been linked by some researchers to repeated seasonal" exact="influenza" post="vaccination in specific antigenically-defined influenza seasons [11]. These effects"/>
 <result pre="some researchers to repeated seasonal influenza vaccination in specific antigenically-defined" exact="influenza" post="seasons [11]. These effects of repeated vaccination was first"/>
 <result pre="statistically determined protective advantage compared to unvaccinated children during seasonal" exact="influenza" post="virus circulation [9,109]. Loss of protection due to repeated"/>
 <result pre="to a greater percentage of vaccinated people testing positive for" exact="influenza" post="virus infections [11]. The evidence supporting the antigen distance"/>
 <result pre="distance hypothesis as a mechanism of reduced effectiveness for specific" exact="influenza" post="seasons remains a hypothesis and is not presented here"/>
 <result pre="hypothesis and is not presented here as leverage for skipping" exact="influenza" post="virus vaccinations. More studies of vaccination effectiveness in other"/>
 <result pre="Furthermore, there are numerous publications supporting the regular use of" exact="influenza" post="vaccinations in children, adults, and pregnant women following rigorous"/>
 <result pre="these analyses support vaccine induced protection against severe disease following" exact="influenza" post="virus infection, as well as improved neonatal outcomes when"/>
 <result pre="of subsequent infections. Previous studies investigating the immune re-encounter with" exact="influenza" post="viral antigens or live virus infection are frequently designed"/>
 <result pre="This design would more accurately reflect the seasonal exposures of" exact="influenza" post="viruses in humans. Longer recovery times for animal experiments"/>
 <result pre="the adaptive immune memory phase will uncover immune mechanisms relating" exact="influenza" post="pathogenesis. Furthermore, since most studies are focused on the"/>
 <result pre="and functions. The standard methodology for assessing immune activation following" exact="influenza" post="virus infection is the HAI (hemagglutinin inhibition) assay which"/>
 <result pre="known that children and infants have different clinical outcomes to" exact="influenza" post="virus infection and vaccination compared to adults [120,121,122]. Infants"/>
 <result pre="Infants and young children are high-risk groups for developing severe" exact="respiratory disease" post="leading to hospitalization following influenza virus infection [102,107], which"/>
 <result pre="groups for developing severe respiratory disease leading to hospitalization following" exact="influenza" post="virus infection [102,107], which may be due to the"/>
 <result pre="Associated Lymphoid Tissue) in the lungs of young animals following" exact="influenza" post="virus infection [125,126]. Despite this evidence, we are unaware"/>
 <result pre="[125,126]. Despite this evidence, we are unaware of any sequential" exact="influenza" post="animal models that imprint during infancy and reinfect during"/>
 <result pre="postpartum [127], it is essential that animal models of recurrent" exact="influenza" post="infection take age into account. Having a more complete"/>
 <result pre="take age into account. Having a more complete understanding of" exact="influenza" post="infection during youth and the immunity gained will guide"/>
 <result pre="immune memory for antigenically variable and dynamic pathogens such as" exact="influenza" post="viruses is limited. The human studies from Andrews and"/>
 <result pre="Concluding Statement The host pathogen interaction of antigenically-evolving and variable" exact="influenza" post="viruses leads to a complex host immune background. Preimmunity"/>
 <result pre="immune background. Preimmunity blends age, immune function, and sequence of" exact="influenza" post="virus infections. By analyzing consecutive influenza virus exposures as"/>
 <result pre="function, and sequence of influenza virus infections. By analyzing consecutive" exact="influenza" post="virus exposures as monosubtypic homologous, monosubtypic heterologous, heterosubtypic, or"/>
 <result pre="future vaccine design and offer insight into an effective universal" exact="influenza" post="vaccine. Although this has been the strategy of universal"/>
 <result pre="influenza vaccine. Although this has been the strategy of universal" exact="influenza" post="vaccine development targeting the HA stalk domain [61], there"/>
 <result pre="memory B cell mechanisms. Findings from animal models of sequential" exact="influenza" post="virus infection may be extrapolated to the knowledge gaps"/>
 <result pre="studies. Understanding how the human immune response changes over sequential" exact="influenza" post="infections and vaccinations will inform the rational development of"/>
 <result pre="Understanding Patterns of Emergence and TransmissionPathogens201656610.3390/pathogens504006627929449 3.BarberisI.MylesP.AultS.K.BragazziN.L.MartiniM.History and evolution of" exact="influenza" post="control through vaccination: From the first monovalent vaccine to"/>
 <result pre="4.NeuK.E.Henry DunandC.J.WilsonP.C.Heads, stalks and everything else: How can antibodies eradicate" exact="influenza" post="as a human disease?Curr. Opin. Immunol.201642485510.1016/j.coi.2016.05.01227268395 5.collab: WHOBiologicals: InfluenzaAvailable"/>
 <result pre="InfluenzaAvailable online: https://www.who.int/biologicals/vaccines/influenza/en/(accessed on December 2018) 6.HayA.J.GregoryV.DouglasA.R.LinY.P.The evolution of human" exact="influenza" post="virusesPhilos. Trans. R. Soc. Lond. B Biol. Sci.20013561861187010.1098/rstb.2001.099911779385 7.FrancisT.J.On"/>
 <result pre="Original Antigenic SinProc. Am. Philos. Soc.1960104572578 8.FonvilleJ.M.WilksS.H.JamesS.L.FoxA.VentrescaM.AbanM.XueL.JonesT.C.LeN.M.H.PhamQ.T.et al.Antibody landscapes after" exact="influenza" post="virus infection or vaccinationScience2014346996100010.1126/science.125642725414313 9.MontoA.S.MaloshR.E.PetrieJ.G.MartinE.T.The Doctrine of Original Antigenic"/>
 <result pre="Good From EvilJ. Infect. Dis.20172151782178810.1093/infdis/jix17328398521 10.LesslerJ.RileyS.ReadJ.M.WangS.ZhuH.SmithG.J.GuanY.JiangC.Q.CummingsD.A.Evidence for antigenic seniority in" exact="influenza" post="A (H3N2) antibody responses in southern ChinaPLoS Pathog.20128e100280210.1371/journal.ppat.100280222829765 11.SkowronskiD.M.ChambersC.De"/>
 <result pre="2010–2011 to 2014–2015J. Infect. Dis.20172151059109910.1093/infdis/jix07428180277 12.MillerM.S.GardnerT.J.KrammerF.AguadoL.C.TortorellaD.BaslerC.F.PaleseP.Neutralizing antibodies against previously encountered" exact="influenza" post="virus strains increase over time: A longitudinal analysisSci. Transl."/>
 <result pre="over time: A longitudinal analysisSci. Transl. Med.20135198ra10710.1126/scitranslmed.300663723946196 13.FangY.BannerD.KelvinA.A.HuangS.S.PaigeC.J.CorfeS.A.KaneK.P.BleackleyR.C.RoweT.LeonA.J.et al.Seasonal H1N1" exact="influenza" post="virus infection induces cross-protective pandemic H1N1 virus immunity through"/>
 <result pre="responses to influenzaSci. Transl. Med.20157316ra19210.1126/scitranslmed.aad052226631631 15.KrammerF.PaleseP.Advances in the development of" exact="influenza" post="virus vaccinesNat. Rev. Drug Discov.20151416718210.1038/nrd452925722244 16.GosticK.M.AmbroseM.WorobeyM.Lloyd-SmithJ.O.Potent protection against H5N1"/>
 <result pre="vaccinesNat. Rev. Drug Discov.20151416718210.1038/nrd452925722244 16.GosticK.M.AmbroseM.WorobeyM.Lloyd-SmithJ.O.Potent protection against H5N1 and H7N9" exact="influenza" post="via childhood hemagglutinin imprintingScience201635472272610.1126/science.aag132227846599 17.HenryC.PalmA.E.KrammerF.WilsonP.C.From Original Antigenic Sin to"/>
 <result pre="Immunol.201839707910.1016/j.it.2017.08.00328867526 18.HancockK.VeguillaV.LuX.ZhongW.ButlerE.N.SunH.LiuF.DongL.DeVosJ.R.GargiulloP.M.et al.Cross-reactive antibody responses to the 2009 pandemic H1N1" exact="influenza" post="virusN. Engl. J. Med.20093611945195210.1056/NEJMoa090645319745214 19.CobeyS.HensleyS.E.Immune history and influenza virus"/>
 <result pre="pandemic H1N1 influenza virusN. Engl. J. Med.20093611945195210.1056/NEJMoa090645319745214 19.CobeyS.HensleyS.E.Immune history and" exact="influenza" post="virus susceptibilityCurr. Opin. Virol.20172210511110.1016/j.coviro.2016.12.00428088686 20.LewnardJ.A.CobeyS.Immune History and Influenza Vaccine"/>
 <result pre="December 2018) 23.HerrlerG.KlenkH.D.Structure and function of the HEF glycoprotein of" exact="influenza" post="C virusAdv. Virus Res.1991402132341957719 24.LofgrenE.FeffermanN.H.NaumovY.N.GorskiJ.NaumovaE.N.Influenza seasonality: Underlying causes and"/>
 <result pre="seasonality: Underlying causes and modeling theoriesJ. Virol.2007815429543610.1128/JVI.01680-0617182688 25.BouvierN.M.PaleseP.The biology of" exact="influenza" post="virusesVaccine200826D49D5310.1016/j.vaccine.2008.07.03919230160 26.TumpeyT.M.BaslerC.F.AguilarP.V.ZengH.SolorzanoA.SwayneD.E.CoxN.J.KatzJ.M.TaubenbergerJ.K.PaleseP.et al.Characterization of the reconstructed 1918 Spanish influenza"/>
 <result pre="of influenza virusesVaccine200826D49D5310.1016/j.vaccine.2008.07.03919230160 26.TumpeyT.M.BaslerC.F.AguilarP.V.ZengH.SolorzanoA.SwayneD.E.CoxN.J.KatzJ.M.TaubenbergerJ.K.PaleseP.et al.Characterization of the reconstructed 1918 Spanish" exact="influenza" post="pandemic virusScience2005310778010.1126/science.111939216210530 27.TaubenbergerJ.K.ReidA.H.LourensR.M.WangR.JinG.FanningT.G.Characterization of the 1918 influenza virus polymerase"/>
 <result pre="reconstructed 1918 Spanish influenza pandemic virusScience2005310778010.1126/science.111939216210530 27.TaubenbergerJ.K.ReidA.H.LourensR.M.WangR.JinG.FanningT.G.Characterization of the 1918" exact="influenza" post="virus polymerase genesNature200543788989310.1038/nature0423016208372 28.PaleseP.WangT.T.Why do influenza virus subtypes die"/>
 <result pre="27.TaubenbergerJ.K.ReidA.H.LourensR.M.WangR.JinG.FanningT.G.Characterization of the 1918 influenza virus polymerase genesNature200543788989310.1038/nature0423016208372 28.PaleseP.WangT.T.Why do" exact="influenza" post="virus subtypes die out? A hypothesisMBio20112e00150-1110.1128/mBio.00150-1121878571 29.KrammerF.PicaN.HaiR.TanG.S.PaleseP.Hemagglutinin Stalk-Reactive Antibodies"/>
 <result pre="Virol.201286103021030710.1128/JVI.01336-1222787225 30.PicaN.HaiR.KrammerF.WangT.T.MaamaryJ.EgginkD.TanG.S.KrauseJ.C.MoranT.SteinC.R.et al.Hemagglutinin stalk antibodies elicited by the 2009 pandemic" exact="influenza" post="virus as a mechanism for the extinction of seasonal"/>
 <result pre="AntibodiesJ. Virol.2015901116112810.1128/JVI.02372-1526559834 32.PaquetteS.G.HuangS.S.BannerD.XuL.LeomicronnA.KelvinA.A.KelvinD.J.Impaired heterologous immunity in aged ferrets during sequential" exact="influenza" post="A H1N1 infectionVirology2014464–46517718310.1016/j.virol.2014.07.013 33.GamblinS.J.SkehelJ.J.Influenza hemagglutinin and neuraminidase membrane glycoproteinsJ."/>
 <result pre="34.ChenX.LiuS.GorayaM.U.MaaroufM.HuangS.ChenJ.L.Host Immune Response to Influenza A Virus InfectionFront. Immunol.2018932010.3389/fimmu.2018.0032029556226 35.HuangS.S.BannerD.PaquetteS.G.LeonA.J.KelvinA.A.KelvinD.J.Pathogenic" exact="influenza" post="B virus in the ferret model establishes lower respiratory"/>
 <result pre="respiratory tract infectionJ. Gen. Virol.2014952127213910.1099/vir.0.064352-024989173 36.BodewesR.MorickD.de MutsertG.OsingaN.BestebroerT.van der VlietS.SmitsS.L.KuikenT.RimmelzwaanG.F.FouchierR.A.et al.Recurring" exact="influenza" post="B virus infections in sealsEmerg. Infect. Dis.20131951151210.3201/eid1903.12096523750359 37.KanegaeY.SugitaS.EndoA.IshidaM.SenyaS.OsakoK.NeromeK.OyaA.Evolutionary pattern"/>
 <result pre="sealsEmerg. Infect. Dis.20131951151210.3201/eid1903.12096523750359 37.KanegaeY.SugitaS.EndoA.IshidaM.SenyaS.OsakoK.NeromeK.OyaA.Evolutionary pattern of the hemagglutinin gene of" exact="influenza" post="B viruses isolated in Japan: Cocirculating lineages in the"/>
 <result pre="monoclonal antibody that targets the fusion domain of group 2" exact="influenza" post="A virus hemagglutininJ. Virol.201488135801359210.1128/JVI.02289-1425210195 40.IwasakiA.PillaiP.S.Innate immunity to influenza virus"/>
 <result pre="group 2 influenza A virus hemagglutininJ. Virol.201488135801359210.1128/JVI.02289-1425210195 40.IwasakiA.PillaiP.S.Innate immunity to" exact="influenza" post="virus infectionNat. Rev. Immunol.20141431532810.1038/nri366524762827 41.ChenJ.DengY.M.Influenza virus antigenic variation, host"/>
 <result pre="&amp;amp; adaptive immunityFuture Virol.2011695196221909336 43.ManicassamyB.ManicassamyS.Belicha-VillanuevaA.PisanelliG.PulendranB.Garcia-SastreA.Analysis of in vivo dynamics of" exact="influenza" post="virus infection in mice using a GFP reporter virusProc."/>
 <result pre="autopsy cases with 2009 H1N1 virus infectionMod. Pathol.20122511310.1038/modpathol.2011.12521874012 45.PanW.DongZ.LiF.MengW.FengL.NiuX.LiC.LuoQ.LiZ.SunC.et al.Visualizing" exact="influenza" post="virus infection in living miceNat. Commun.20134236910.1038/ncomms336924022374 46.PulendranB.MaddurM.S.Innate immune sensing"/>
 <result pre="respond to different microbial antigensJ. Exp. Med.200119486386910.1084/jem.194.6.86311561001 49.IchinoheT.LeeH.K.OguraY.FlavellR.IwasakiA.Inflammasome recognition of" exact="influenza" post="virus is essential for adaptive immune responsesJ. Exp. Med.2009206798710.1084/jem.2008166719139171"/>
 <result pre="essential for adaptive immune responsesJ. Exp. Med.2009206798710.1084/jem.2008166719139171 50.WaithmanJ.MinternJ.D.Dendritic cells and" exact="influenza" post="A virus infectionVirulence2012360360810.4161/viru.2186423076333 51.LeonA.J.BannerD.XuL.RanL.PengZ.YiK.ChenC.XuF.HuangJ.ZhaoZ.et al.Sequencing, annotation, and characterization of"/>
 <result pre="A virus infectionVirulence2012360360810.4161/viru.2186423076333 51.LeonA.J.BannerD.XuL.RanL.PengZ.YiK.ChenC.XuF.HuangJ.ZhaoZ.et al.Sequencing, annotation, and characterization of the" exact="influenza" post="ferret infectomeJ. Virol.2013871957196610.1128/JVI.02476-1223236062 52.RoweT.LeonA.J.CrevarC.J.CarterD.M.XuL.RanL.FangY.CameronC.M.CameronM.J.BannerD.et al.Modeling host responses in ferrets"/>
 <result pre="infectomeJ. Virol.2013871957196610.1128/JVI.02476-1223236062 52.RoweT.LeonA.J.CrevarC.J.CarterD.M.XuL.RanL.FangY.CameronC.M.CameronM.J.BannerD.et al.Modeling host responses in ferrets during A/California/07/2009" exact="influenza" post="infectionVirology201040125726510.1016/j.virol.2010.02.02020334888 53.SunJ.BracialeT.J.Role of T cell immunity in recovery from"/>
 <result pre="influenza infectionVirology201040125726510.1016/j.virol.2010.02.02020334888 53.SunJ.BracialeT.J.Role of T cell immunity in recovery from" exact="influenza" post="virus infectionCurr. Opin. Virol.2013342542910.1016/j.coviro.2013.05.00123721865 54.GrantE.J.Quinones-ParraS.M.ClemensE.B.KedzierskaK.Human influenza viruses and CD8(+)"/>
 <result pre="immunity in recovery from influenza virus infectionCurr. Opin. Virol.2013342542910.1016/j.coviro.2013.05.00123721865 54.GrantE.J.Quinones-ParraS.M.ClemensE.B.KedzierskaK.Human" exact="influenza" post="viruses and CD8(+) T cell responsesCurr. Opin. Virol.20161613214210.1016/j.coviro.2016.01.01626974887 55.HuffordM.M.KimT.S.SunJ.BracialeT.J.Antiviral"/>
 <result pre="vivoJ. Immunol.20111864599460810.4049/jimmunol.100197221389258 57.SunJ.MadanR.KarpC.L.BracialeT.J.Effector T cells control lung inflammation during acute" exact="influenza" post="virus infection by producing IL-10Nat. Med.20091527728410.1038/nm.192919234462 58.McKinstryK.K.StruttT.M.BuckA.CurtisJ.D.DibbleJ.P.HustonG.TigheM.HamadaH.SellS.DuttonR.W.et al.IL-10 deficiency"/>
 <result pre="and vaccinesCurr. Opin. Virol.2013352153010.1016/j.coviro.2013.07.00723978327 62.BuiH.H.PetersB.AssarssonE.MbawuikeI.SetteA.Ab and T cell epitopes of" exact="influenza" post="A virus, knowledge and opportunitiesProc. Natl. Acad. Sci. USA200710424625110.1073/pnas.060933010417200302"/>
 <result pre="knowledge and opportunitiesProc. Natl. Acad. Sci. USA200710424625110.1073/pnas.060933010417200302 63.EllebedyA.H.WebbyR.J.Influenza vaccinesVaccine200927D65D6810.1016/j.vaccine.2009.08.03819837290 64.MontoA.S.Seasonal" exact="influenza" post="and vaccination coverageVaccine201028D33D4410.1016/j.vaccine.2010.08.02720713259 65.TangyeS.G.TarlintonD.M.Memory B cells: Effectors of long-lived"/>
 <result pre="longevity of natural killer cellsImmunol. Rev.2010236839410.1111/j.1600-065X.2010.00900.x20636810 69.ChiuC.EllebedyA.H.WrammertJ.AhmedR.B cell responses to" exact="influenza" post="infection and vaccinationCurr. Top. Microbiol. Immunol.201538638139825193634 70.LipsitchM.ViboudC.Influenza seasonality: Lifting"/>
 <result pre="the fogProc. Natl. Acad. Sci. USA20091063645364610.1073/pnas.090093310619276125 71.SmithW.AndrewesC.H.LaidlawP.A virus isolated from" exact="influenza" post="patientsLancet1933225666810.1016/S0140-6736(00)78541-2 72.YangJ.R.HuangY.P.ChangF.Y.HsuL.C.LinY.C.HuangH.Y.WuF.T.WuH.S.LiuM.T.Phylogenetic and evolutionary history of influenza B viruses,"/>
 <result pre="virus isolated from influenza patientsLancet1933225666810.1016/S0140-6736(00)78541-2 72.YangJ.R.HuangY.P.ChangF.Y.HsuL.C.LinY.C.HuangH.Y.WuF.T.WuH.S.LiuM.T.Phylogenetic and evolutionary history of" exact="influenza" post="B viruses, which caused a large epidemic in 2011–2012,"/>
 <result pre="large epidemic in 2011–2012, TaiwanPLoS ONE20127e4717910.1371/journal.pone.004717923071751 73.HannounC.The evolving history of" exact="influenza" post="viruses and influenza vaccinesExpert Rev. Vacc.2013121085109410.1586/14760584.2013.82470924024871 74.TaubenbergerJ.K.ReidA.H.JanczewskiT.A.FanningT.G.Integrating historical, clinical"/>
 <result pre="2011–2012, TaiwanPLoS ONE20127e4717910.1371/journal.pone.004717923071751 73.HannounC.The evolving history of influenza viruses and" exact="influenza" post="vaccinesExpert Rev. Vacc.2013121085109410.1586/14760584.2013.82470924024871 74.TaubenbergerJ.K.ReidA.H.JanczewskiT.A.FanningT.G.Integrating historical, clinical and molecular genetic"/>
 <result pre="to explain the origin and virulence of the 1918 Spanish" exact="influenza" post="virusPhilos. Trans. R Soc. Lond. B Biol. Sci.20013561829183910.1098/rstb.2001.102011779381 75.WorobeyM.HanG.Z.RambautA.Genesis"/>
 <result pre="Biol. Sci.20013561829183910.1098/rstb.2001.102011779381 75.WorobeyM.HanG.Z.RambautA.Genesis and pathogenesis of the 1918 pandemic H1N1" exact="influenza" post="A virusProc. Natl. Acad. Sci. USA20141118107811210.1073/pnas.132419711124778238 76.TaubenbergerJ.K.ReidA.H.KrafftA.E.BijwaardK.E.FanningT.G.Initial genetic characterization"/>
 <result pre="Acad. Sci. USA20141118107811210.1073/pnas.132419711124778238 76.TaubenbergerJ.K.ReidA.H.KrafftA.E.BijwaardK.E.FanningT.G.Initial genetic characterization of the 1918 &quot;Spanish&quot;" exact="influenza" post="virusScience19972751793179610.1126/science.275.5307.17939065404 77.SmithG.J.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic influenza virusesProc. Natl."/>
 <result pre="the 1918 &quot;Spanish&quot; influenza virusScience19972751793179610.1126/science.275.5307.17939065404 77.SmithG.J.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic" exact="influenza" post="virusesProc. Natl. Acad. Sci. USA2009106117091171210.1073/pnas.090499110619597152 78.WertheimJ.O.The re-emergence of H1N1"/>
 <result pre="influenza virusesProc. Natl. Acad. Sci. USA2009106117091171210.1073/pnas.090499110619597152 78.WertheimJ.O.The re-emergence of H1N1" exact="influenza" post="virus in 1977: A cautionary tale for estimating divergence"/>
 <result pre="United StatesAvailable online: https://www.cdc.gov/flu/about/disease/burden-averted-vaccination.htm.(accessed on December 2018) 80.ShindeV.BridgesC.B.UyekiT.M.ShuB.BalishA.XuX.LindstromS.GubarevaL.V.DeydeV.GartenR.J.et al.Triple-reassortant swine" exact="influenza" post="A (H1) in humans in the United States, 2005–2009N."/>
 <result pre="United States, 2005–2009N. Engl. J. Med.20093602616262510.1056/NEJMoa090381219423871 81.LaiS.QinY.CowlingB.J.RenX.WardropN.A.GilbertM.TsangT.K.WuP.FengL.JiangH.et al.Global epidemiology of" exact="avian influenza" post="A H5N1 virus infection in humans, 1997–2015: A systematic"/>
 <result pre="States, 2005–2009N. Engl. J. Med.20093602616262510.1056/NEJMoa090381219423871 81.LaiS.QinY.CowlingB.J.RenX.WardropN.A.GilbertM.TsangT.K.WuP.FengL.JiangH.et al.Global epidemiology of avian" exact="influenza" post="A H5N1 virus infection in humans, 1997–2015: A systematic"/>
 <result pre="of individual case dataLancet Infect. Dis.201616e108e11810.1016/S1473-3099(16)00153-527211899 82.SubbaraoK.KlimovA.KatzJ.RegneryH.LimW.HallH.PerdueM.SwayneD.BenderC.HuangJ.et al.Characterization of an" exact="avian influenza" post="A (H5N1) virus isolated from a child with a"/>
 <result pre="individual case dataLancet Infect. Dis.201616e108e11810.1016/S1473-3099(16)00153-527211899 82.SubbaraoK.KlimovA.KatzJ.RegneryH.LimW.HallH.PerdueM.SwayneD.BenderC.HuangJ.et al.Characterization of an avian" exact="influenza" post="A (H5N1) virus isolated from a child with a"/>
 <result pre="Influenza Virus: Evidence for Anti-PA-X AntibodiesJ. Virol.2016909383939310.1128/JVI.01408-1627512055 84.PeirisM.YuenK.Y.LeungC.W.ChanK.H.IpP.L.LaiR.W.OrrW.K.ShortridgeK.F.Human infection with" exact="influenza" post="H9N2Lancet199935491691710.1016/S0140-6736(99)03311-510489954 85.collab: CDCHuman Infection with Highly Pathogenic A(H7N7) Avian"/>
 <result pre="Secondary Immune Responses to Influenza VirusesPLoS Pathog.201612e100580610.1371/journal.ppat.100580627537358 89.DuttaA.HuangC.T.LinC.Y.ChenT.C.LinY.C.ChangC.S.HeY.C.Sterilizing immunity to" exact="influenza" post="virus infection requires local antigen-specific T cell response in"/>
 <result pre="in the lungsSci. Rep.201663297310.1038/srep3297327596047 90.EllebedyA.H.AhmedR.Re-engaging cross-reactive memory B cells: The" exact="influenza" post="puzzleFront. Immunol.201235310.3389/fimmu.2012.0005322566934 91.O’NeillE.KraussS.L.RiberdyJ.M.WebsterR.G.WoodlandD.L.Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza"/>
 <result pre="The influenza puzzleFront. Immunol.201235310.3389/fimmu.2012.0005322566934 91.O’NeillE.KraussS.L.RiberdyJ.M.WebsterR.G.WoodlandD.L.Heterologous protection against lethal A/HongKong/156/97 (H5N1)" exact="influenza" post="virus infection in C57BL/6 miceJ. Gen. Virol.2000812689269610.1099/0022-1317-81-11-268911038381 92.LaMereM.W.LamH.T.MoquinA.HaynesL.LundF.E.RandallT.D.KaminskiD.A.Contributions of"/>
 <result pre="Gen. Virol.2000812689269610.1099/0022-1317-81-11-268911038381 92.LaMereM.W.LamH.T.MoquinA.HaynesL.LundF.E.RandallT.D.KaminskiD.A.Contributions of antinucleoprotein IgG to heterosubtypic immunity against" exact="influenza" post="virusJ. Immunol.20111864331433910.4049/jimmunol.100305721357542 93.LaurieK.L.CarolanL.A.MiddletonD.LowtherS.KelsoA.BarrI.G.Multiple infections with seasonal influenza A virus"/>
 <result pre="heterosubtypic immunity against influenza virusJ. Immunol.20111864331433910.4049/jimmunol.100305721357542 93.LaurieK.L.CarolanL.A.MiddletonD.LowtherS.KelsoA.BarrI.G.Multiple infections with seasonal" exact="influenza" post="A virus induce cross-protective immunity against A(H1N1) pandemic influenza"/>
 <result pre="seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic" exact="influenza" post="virus in a ferret modelJ. Infect. Dis.20102021011102010.1086/65618820715930 94.LiY.MyersJ.L.BostickD.L.SullivanC.B.MadaraJ.LindermanS.L.LiuQ.CarterD.M.WrammertJ.EspositoS.et al.Immune"/>
 <result pre="Infect. Dis.20102021011102010.1086/65618820715930 94.LiY.MyersJ.L.BostickD.L.SullivanC.B.MadaraJ.LindermanS.L.LiuQ.CarterD.M.WrammertJ.EspositoS.et al.Immune history shapes specificity of pandemic H1N1" exact="influenza" post="antibody responsesJ. Exp. Med.20132101493150010.1084/jem.2013021223857983 95.KosikovaM.LiL.RadvakP.YeZ.WanX.F.XieH.Imprinting of Repeated Influenza A/H3"/>
 <result pre="and Transmission in FerretsJ. Virol.2015903268327310.1128/JVI.02481-1526719251 100.MonsalvoA.C.BatalleJ.P.LopezM.F.KrauseJ.C.KlemencJ.HernandezJ.Z.MaskinB.BugnaJ.RubinsteinC.AguilarL.et al.Severe pandemic 2009 H1N1" exact="influenza" post="disease due to pathogenic immune complexesNat. Med.20111719519910.1038/nm.226221131958 101.collab: PHACFluwatch,"/>
 <result pre="mediocre?Science20173571222122310.1126/science.357.6357.122228935783 109.HoskinsT.W.DaviesJ.R.SmithA.J.MillerC.L.AllchinA.Assessment of inactivated influenza-A vaccine after three outbreaks of" exact="influenza" post="A at Christ’s HospitalLancet19791333510.1016/S0140-6736(79)90468-983475 110.SkowronskiD.M.ChambersC.De SerresG.SabaiducS.WinterA.L.DickinsonJ.A.GubbayJ.B.DrewsS.J.FonsecaK.CharestH.et al.Vaccine effectiveness against"/>
 <result pre="HospitalLancet19791333510.1016/S0140-6736(79)90468-983475 110.SkowronskiD.M.ChambersC.De SerresG.SabaiducS.WinterA.L.DickinsonJ.A.GubbayJ.B.DrewsS.J.FonsecaK.CharestH.et al.Vaccine effectiveness against lineage matched and mismatched" exact="influenza" post="B viruses across 8 seasons in Canada, 2010–2011 to"/>
 <result pre="of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal" exact="influenza" post="virus vaccineJ. Infect. Dis.20001811133113710.1086/31532310720541 112.LeggeA.DoddsL.MacDonaldN.E.ScottJ.McNeilS.Rates and determinants of seasonal"/>
 <result pre="influenza virus vaccineJ. Infect. Dis.20001811133113710.1086/31532310720541 112.LeggeA.DoddsL.MacDonaldN.E.ScottJ.McNeilS.Rates and determinants of seasonal" exact="influenza" post="vaccination in pregnancy and association with neonatal outcomesCMAJ2014186E157E16410.1503/cmaj.13049924396098 113.ThompsonM.G.KwongJ.C.ReganA.K.KatzM.A.DrewsS.J.Azziz-BaumgartnerE.KleinN.P.ChungH.EfflerP.V.FeldmanB.S.et"/>
 <result pre="Design Study, 2010–2016Clin. Infec.t Dis.201810.1093/cid/ciy73730307490 114.NicholK.L.MendelmanP.M.MallonK.P.JacksonL.A.GorseG.J.BelsheR.B.GlezenW.P.WittesJ.Effectiveness of live, attenuated intranasal" exact="influenza" post="virus vaccine in healthy, working adults: A randomized controlled"/>
 <result pre="system, co-administered or sequentially administered with an inactivated trivalent seasonal" exact="influenza" post="vaccineBMC Infect. Dis.20121227910.1186/1471-2334-12-27923110320 122.LangleyJ.M.WangL.AggarwalN.BuesoA.ChandrasekaranV.CousinL.HalperinS.A.LiP.LiuA.McNeilS.et al.Immunogenicity and Reactogenicity of an"/>
 <result pre="Multicenter, Multicountry, Clinical TrialJ. Pediatr. Infect. Dis. Soc.2015424225110.1093/jpids/piu09826336604 123.CollieM.H.RushtonD.I.SweetC.SmithH.Studies of" exact="influenza" post="virus infection in newborn ferretsJ. Med. Microbiol.19801356157110.1099/00222615-13-4-5617431374 124.PaquetteS.G.BannerD.HuangS.S.AlmansaR.LeonA.XuL.BartoszkoJ.KelvinD.J.KelvinA.A.Influenza Transmission"/>
 <result pre="infections and vaccinations. The schematic illustrates possible immune fluctuations following" exact="influenza" post="virus infection or vaccination. Immune fluctuations and potential protection"/>
 <result pre="genetic and antigenic relatedness. Immune specificity that is gained during" exact="influenza" post="virus immune imprinting during infancy or childhood leading to"/>
 <result pre="basic 2 (PB2). Figure 3 Timeline of the history of" exact="influenza" post="virus circulation in humans since 1890s. The timeline shows"/>
 <result pre="in humans since 1890s. The timeline shows the history of" exact="influenza" post="virus type A and B circulation since 1890. There"/>
 <result pre="pandemic of ~1891 occurred prior to the discovery of the" exact="influenza" post="virus and is known only by historical medical records."/>
 <result pre="circulation from the 1977 lineage. In addition to circulating seasonal" exact="influenza" post="viruses, avian virus spillover events also lead to human"/>
 <result pre="virus spillover events occurred in 1997 and 2013 for the" exact="influenza" post="A viruses H5N1 and H7N9, respectively. During this time"/>
 <result pre="A viruses H5N1 and H7N9, respectively. During this time period," exact="influenza" post="B viruses have also co-circulated in humans. *Image credit"/>
 <result pre="humans. *Image credit CDC for the 1918 pandemic and the" exact="influenza" post="virion [79]. Figure 4 Influenza immune imprinting and the"/>
 <result pre="Figure 4 Influenza immune imprinting and the history of circulating" exact="influenza" post="viruses. The timeline illustrates the relationship between virus circulation"/>
 <result pre="viruses. The timeline illustrates the relationship between virus circulation and" exact="influenza" post="virus immune imprinting at infancy. Several published studies have"/>
</results>
